Reducing Treatment Doses in Head and Neck Cancer to Improve QOL
In this video we discuss efforts to reduce treatment doses in order to lessen long-term side effects and improve quality of life among patients with head and neck cancers.
HPV Blood Test Could Predict Prognosis in Head and Neck Cancer
Head and neck cancer patients who have a human papillomavirus (HPV) infection detectable with a blood-based biomarker have a better prognosis compared with HPV-negative patients.
Higher Facility Volume Linked With Better Radiation Outcomes for Head and Neck Cancers
A study presented last month at ASTRO found that better radiation outcomes for head and neck cancer were associated with higher facility volume.
Chronic Sinusitis Linked to Head and Neck Cancers in Elderly
Chronic sinusitis is associated with three rare types of head and neck cancer, including nasopharyngeal cancer, HPV-related oropharyngeal cancer, and nasal cavity and paranasal sinus cancers.
FDA Grants Nivolumab Priority Review in Head and Neck Cancer
In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses the recent priority review of nivolumab for use in metastatic head and neck cancer.
Ernest Hawk Discusses the NCI-Designated Cancer Centers’ Joint Statement on the HPV Vaccine
In this interview we discuss a joint statement from MD Anderson and 68 other NCI-designated cancer centers that calls for increased HPV vaccination for the prevention of cancer.
Induction Chemo in Head and Neck Cancer: Is the Jury Still Out?
To date, there is still no strong evidence that induction chemotherapy improves outcomes for locally advanced head and neck cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.